Updated on 2 July 2012
Ibandronate sodium tablets are a bioequivalent of Boniva tablets
Bangalore: Dr. Reddy's Laboratories has launched Ibandronate sodium tablets (150 mg), a bioequivalent generic version of Boniva tablets in the US market, following the approval by the US Food & Drug Administration (FDA) of its abbreviated new drug application.
The Boniva brand and generic had US sales of approximately $486 million for the twelve months ending March 2012, according to IMS Health. Dr. Reddy's Ibandronate sodium tablets in 150 mg are available in cartons of three blister packs containing one tablet each (once monthly dosing).
Survey Box
Subscribe to BioSpectrum Asia digital mag at an attractive price of US $49.99 a year
(Includes all 24 regular & special issues @ fortnightly frequency)
Send this article by email
Australia
China
India
Japan
Korea
Malaysia
New Zealand 
Singapore
Taiwan
Thailand
